Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$50.42 - $64.29 $201 - $257
4 Added 0.0%
80,078 $4.82 Million
Q1 2024

May 13, 2024

SELL
$35.51 - $57.92 $486,273 - $793,156
-13,694 Reduced 14.6%
80,074 $4.13 Million
Q4 2023

Feb 13, 2024

BUY
$20.91 - $40.9 $1.96 Million - $3.84 Million
93,768 New
93,768 $3.78 Million
Q2 2022

Aug 12, 2022

BUY
$10.61 - $16.66 $1.05 Million - $1.65 Million
99,317 New
99,317 $1.4 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $840M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.